Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Blachly

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Blood|February 14, 2015
Separating the wheat from the chaff in cHLJames S Blachly
Blood|February 27, 2016
Ribosomal revelationJames S Blachly
Current Hematologic Malignancy Reports|February 20, 2016
Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted AgentsJoseph Maly, James S Blachly
British Journal of Haematology|August 8, 2014
Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphomaJames S Blachly, Robert A Baiocchi
Leukemia & Lymphoma|March 16, 2013
Emerging drug profile: cyclin-dependent kinase inhibitorsJames S Blachly, John C Byrd
Seminars in Oncology|April 5, 2016
Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemiaJames S Blachly, John C Byrd, Michael Grever
The New England Journal of Medicine|December 29, 2018
Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and PancytopeniaKerry A Rogers, James S Blachly, Michael R Grever
Haematologica|December 1, 2022
The present and future of measurable residual disease testing in acute myeloid leukemiaJames S Blachly, Roland B Walter, Christopher S Hourigan
Blood Reviews|August 12, 2014
Hairy cell leukemia: Update on molecular profiling and therapeutic advancesMichael R Grever, James S Blachly, Leslie A Andritsos
Scientific Reports|February 9, 2020
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon BarcodesEmily M Teets, Charles Gregory, Jami Shaffer, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Blood|February 14, 2015
Separating the wheat from the chaff in cHLJames S Blachly
Blood|February 27, 2016
Ribosomal revelationJames S Blachly
Current Hematologic Malignancy Reports|February 20, 2016
Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted AgentsJoseph Maly, James S Blachly
British Journal of Haematology|August 8, 2014
Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphomaJames S Blachly, Robert A Baiocchi
Leukemia & Lymphoma|March 16, 2013
Emerging drug profile: cyclin-dependent kinase inhibitorsJames S Blachly, John C Byrd
Seminars in Oncology|April 5, 2016
Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemiaJames S Blachly, John C Byrd, Michael Grever
The New England Journal of Medicine|December 29, 2018
Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and PancytopeniaKerry A Rogers, James S Blachly, Michael R Grever
Haematologica|December 1, 2022
The present and future of measurable residual disease testing in acute myeloid leukemiaJames S Blachly, Roland B Walter, Christopher S Hourigan
Blood Reviews|August 12, 2014
Hairy cell leukemia: Update on molecular profiling and therapeutic advancesMichael R Grever, James S Blachly, Leslie A Andritsos
Scientific Reports|February 9, 2020
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon BarcodesEmily M Teets, Charles Gregory, Jami Shaffer, et al.
Pageof 12